Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance, with increased R&D and marketing investments, and a healthy cash balance. The Q&A highlights optimism about market expansion and new product initiatives, despite some concerns about the longer sales cycle for a key program. The overall sentiment is positive, with growth in digital health and potential international expansion. The absence of negative trends and the anticipation of new deals support a stock price increase prediction.
Key Financial Performance
Revenue Total revenue for the first quarter of 2026 was $8.8 million, representing approximately 9% growth year-over-year. The growth was more moderate compared to prior periods due to the current stage of scaling the business rather than any change in underlying demand or platform scalability.
Adjusted EBITDA Adjusted EBITDA for the first quarter was negative $1.3 million compared to positive $1.2 million in the prior year period. This reflects planned increases in investment across key growth initiatives, particularly in sales and marketing and product development.
Net Loss Net loss for the first quarter was $1.6 million compared to net income of $0.5 million in the prior year period. This reflects increased investment in growth initiatives.
Operating Expenses Total operating expenses for the quarter were $6.7 million, approximately 76% of revenue, compared to $4.9 million or 41% of revenue in the prior year. The increase reflects deliberate investments in sales distribution, marketing, and product development.
Sales and Marketing Expenses Sales and marketing expenses were $2.3 million, representing approximately 26% of revenue, compared to $1.1 million or 14% of revenue in the prior year. This increase reflects deliberate investment in expanding sales distribution footprint and building a scalable go-to-market infrastructure.
General and Administrative Expenses General and administrative expenses were $3.5 million, representing approximately 39% of revenue, compared to $3.2 million or 41% of revenue in the prior year. The increase reflects continued team building while managing a lower percentage of revenue to be more scalable.
Research and Development Expenses Research and development expenses were $0.9 million, representing approximately 10% of revenue, compared to $0.5 million or 7% of revenue in the prior year. This increase reflects continued investment in technology capabilities and new product initiatives.
Cash Balance The company ended the quarter with $10.3 million in cash and cash equivalents, reflecting proceeds from recent private financing.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Enhanced self-funded plan administration offering: Launched in January 2026, this new model delivers pre-configured end-to-end self-funded health benefit solutions that bundle plan design, administration, and stop-loss coverage into a single streamlined framework. It includes over 100 customized plans supported by specialized administrative vendors.
eDIYBS platform updates: Significant updates include a refreshed interface, improved workflow design, enhanced census insights, expanded large group quoting functionality, automated experience data parsing, AI-driven risk insights, and broker-to-underwriter messaging. These updates aim to reduce manual work and improve quoting and underwriting outcomes.
3-year rate stabilization program: Currently under development, this program aims to address pricing volatility and provide greater cost predictability for employer groups. Market testing is expected in late Q2 to Q3 2026.
Data-driven solution integrating psychological and claims data: Beta testing is anticipated to begin in Q2 2026. This solution aims to generate actionable value insights for partners and clients.
Expansion of broker network: Investments in sales and marketing are being made to expand the broker network and build a scalable go-to-market strategy. The company plans to increase direct broker engagement through conferences, targeted outreach, and brand awareness initiatives.
Addition of new carrier partners: Efforts are underway to increase the number and diversity of participating insurance carriers, providing brokers with more options and improving platform utilization.
Technology architecture and AI development: Partnership with Ciklum to enhance platform capabilities, streamline data infrastructure, and improve integration of workflows. This includes consolidating quoting, underwriting, administration, and analytics into a unified platform.
Operational efficiency improvements: Updates to the eDIYBS platform have reduced manual work, improved visibility, and supported faster, more accurate quoting and underwriting outcomes.
Targeted investments for growth: The company is deliberately investing in sales, distribution, and technology development to expand its market presence and accelerate long-term revenue growth.
Focus on large employer accounts: Scaling capabilities to target larger employer accounts, which is expected to increase average contract value and improve close and renewal rates.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Penetration: The company's penetration of the broker pool remains below 0.1%, indicating a significant challenge in capturing a larger market share despite the substantial benefits of their platform.
Sales and Distribution Expansion: The company is heavily reliant on brokers for distribution, and its current sales team is small. Scaling the sales team and expanding the broker network is critical but poses challenges in terms of cost and execution.
Carrier Network Expansion: The limited number of participating insurance carriers on the platform can lead to pricing volatility and limited options for employers at renewal, potentially impacting customer retention and satisfaction.
Technology Development: The company is investing heavily in technology and AI development, which is resource-intensive and may face challenges in achieving scalability, data intelligence, cybersecurity, and operational resilience.
Economic and Financial Risks: The company reported a net loss of $1.6 million in the first quarter of 2026, reflecting increased operating expenses and deliberate investments in growth initiatives, which could strain financial resources if revenue growth does not materialize as expected.
Regulatory and Compliance Risks: The company operates in the self-funded health insurance market, which is subject to regulatory scrutiny and potential changes in laws that could impact operations and profitability.
Customer Retention and Satisfaction: Fluctuations in carrier underwriting criteria and risk assessment can lead to less competitive pricing or limited options for employers, potentially affecting customer retention and satisfaction.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance: The company reiterates its full-year 2026 revenue guidance of $45 million to $50 million, representing approximately 35% to 50% year-over-year growth.
Investment Plans: The company plans deliberate investments in sales, distribution, and technology development to expand its broker network, enhance technology, and accelerate long-term revenue growth.
Capital Deployment: The $7 million raised through a private investment will be used to expand the sales distribution network, add new carrier partners, enhance technology architecture and AI development, and advance service offerings and product development.
Technology Enhancements: The company is implementing a more integrated technology environment with enhanced platform capabilities, administrative functions, and advanced data reporting to support scalability and improve decision-making.
Product Development: The company is developing a 3-year rate stabilization program to address pricing volatility and provide cost predictability for employer groups. Market testing is expected to be completed in late Q2 to Q3 2026.
Beta Testing: Initial beta testing of a new data-driven solution integrating psychological and claims data is anticipated to commence in Q2 2026.
Market Opportunity: The company aims to capture a larger share of the $1 trillion self-funded health insurance market by expanding its ecosystem and democratizing self-funded health insurance for all employers.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you walk through the key expansion areas such as expanding sales, broadening marketing activities, developing the new marketplace, and enhancing the tech architecture?
A:The company has penetrated a small portion of the broker market and plans to hire 2-3 sales reps focused on outbound efforts. They aim to improve marketing messages to increase broker visibility and understanding of their platform. Positive broker feedback has been received, and they are optimistic about growth.
Q:How is the rollout of the 100 pre-configured plan options working in the market?
A:The pre-configured health plans simplify the process for brokers by providing package plans that make it easier to evaluate rates against employer renewals. This approach is a proven playbook in the health insurance world.
Q:What progress has been made on the 3-year rate stabilization plan, and is there potential demand?
A:The program has been modified to be carrier-agnostic and is gaining traction. Proposals are being prepared for self-funded groups, and the company anticipates securing at least one deal in the second quarter. Financially, they expect sales to start in the fourth quarter, but there is potential for earlier results.
Q:Can you explain the new metric of platform place land value of $82 million and its correlation to revenue?
A:The $82 million represents the total value of self-funded plans placed through the platform over 12 months. Revenue is recognized monthly over the contract period. For example, $8.8 million was reported in Q1, with $22.9 million remaining to be recognized in the year, totaling $31.6 million.
Q:Does the platform place land value include the full 12-month value of plans written earlier in the year?
A:Yes, the value includes the full 12-month contract. For example, a plan written in February will have revenue recognized monthly from February to the following January. The remaining revenue for the year is also reported for better visibility.
Q:What happens if underwriting performance is poor in the 3-year rate plan, and how does the sales cycle align with renewal seasons?
A:If underwriting performance is poor, the excess of loss insurance policy would be used. The sales cycle aligns with renewal seasons, primarily in July and January. Testing is underway to prepare for quoting and addressing broker questions before finalizing deals.
Q:What were the costs associated with the Davos conference and other non-recurring expenses in Q1?
A:The Davos conference cost approximately $200,000, and about $100,000 of other costs were non-recurring.
Q:Is the 3-year rate stabilization feature expected to have a longer sales cycle, and what is the level of interest?
A:Yes, the feature targets larger employers, which typically have longer sales cycles. There is significant interest, and the program has been refined to be carrier-agnostic, offering opportunities for both new business and renewals.
Q:How will revenue be recognized for the 3-year rate stabilization program, and will there be any upfront deposits?
A:Revenue will be recognized monthly from the effective date, similar to 1-year programs. There are no upfront deposits required; underwriting spreads costs across the 3 years.
Q:Can the analytics capabilities extend beyond the initial target market?
A:Yes, there is significant potential to extend analytics capabilities beyond the initial target market, with opportunities to package data for broader applications.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct answer regarding the potential risk of missing this year's renewal season for the 3-year rate stabilization plan. They acknowledged the longer sales cycle but did not address the specific risk of delays in broker understanding or adoption.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI
benefit
broker
capability
capital
carrier risk
census insight
client
communication
cost
development
distribution partner
employer
engagement
experience
group
house sale
industry
insurance
loss
market
model
network
opportunity
plan
platform
process
quoting underwriting
renewal
sale distribution
self health
service
solution
technology
update
vendor
visibility
workflow
HIT Transcript
Health In Tech, Inc. (HIT) Q1 2026 Earnings Call Transcript
Positive5-14
The earnings call reveals strong financial performance, with increased R&D and marketing investments, and a healthy cash balance. The Q&A highlights optimism about market expansion and new product initiatives, despite some concerns about the longer sales cycle for a key program. The overall sentiment is positive, with growth in digital health and potential international expansion. The absence of negative trends and the anticipation of new deals support a stock price increase prediction.
Health In Tech, Inc. (HIT) Q4 2025 Earnings Call Transcript
Positive3-26
The earnings call reveals strong financial performance with a 20% YoY revenue increase, improved gross margins, and a 25% rise in net income. The company's strategic initiatives in digital health and market expansion, along with robust revenue growth expectations for 2026, further support a positive outlook. The absence of negative sentiment in the Q&A section and stable margin projections contribute to a positive sentiment rating.
Health In Tech, Inc. (HIT) Q3 2025 Earnings Call Transcript
Positive11-11
The earnings call reflects strong financial health with improved operating expenses and positive cash flow. Strategic partnerships and product innovations are expected to drive growth. Despite some uncertainties in the large employer market, the company's initiatives like the 3-year rate hold and blockchain development are promising. The Q&A session revealed positive analyst sentiment, although some details were withheld. Overall, the positive financial performance and strategic growth plans suggest a positive stock price movement in the near term.
Health In Tech, Inc. (HIT) Q2 2025 Earnings Call Transcript
Positive7-23
The earnings call summary indicates strong financial performance with positive cash flow, effective cost management, and strategic partnerships driving growth. The Q&A reveals management's proactive approach in leveraging partnerships and technology for market expansion, despite some vague responses about new products. The company's solid financial health and growth strategy, coupled with a significant market opportunity, suggest a positive stock price movement. However, the lack of specific guidance on new products and potential expansion limits the sentiment from being 'strong positive.'
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
